[Federal Register Volume 75, Number 122 (Friday, June 25, 2010)]
[Notices]
[Page 36432]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-15554]
[[Page 36432]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0001]
Tobacco Products Scientific Advisory Committee; Amendment of
Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing an amendment
to the notice of meeting of the Tobacco Products Scientific Advisory
Committee. This meeting was announced in the Federal Register of May
19, 2010 (75 FR 28027). The amendment is being made to reflect a change
in the Agenda and Procedure portions of the document. The Agenda
portion is changed to cancel Topic 1 regarding dissolvable tobacco
products. This portion of the meeting has been cancelled. The Procedure
portion is changed to a 1-hour open public hearing from 10 a.m. to 11
a.m. on July 16, 2010. There are no other changes.
FOR FURTHER INFORMATION CONTACT: Cristi Stark, Center for Tobacco
Products, Food and Drug Administration, 9200 Corporate Blvd, Rockville,
MD 20850, 1-877-287-1373 (choose Option 4), e-mail: [email protected]
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington DC area), code 8732110002. Please call the
Information Line for up-to-date information on this meeting.
SUPPLEMENTARY INFORMATION: In the Federal Register of May 19, 2010 (75
FR 28027), FDA announced that a meeting of the Tobacco Products
Scientific Advisory Committee would be held on July 15 and 16, 2010. On
page 28027, in the first column, the Agenda portion of the document is
changed to read as follows:
Agenda: On July 15, 2010, the committee will: (1) Receive updates
on upcoming committee business related to menthol, including Agency
requests for information from industry on menthol cigarettes in order
to prepare for the Tobacco Products Scientific Advisory Committee's
required report to the Secretary of Health and Human Services regarding
the impact of use of menthol in cigarettes on the public health and (2)
hear and discuss industry presentations on menthol in cigarettes as
they relate to the following five topics: Characterization of menthol,
clinical effects of menthol, biomarkers of disease risk, marketing
data, and population effects.
On page 28027, in the third column, the Agenda portion of the
document is changed to read as follows:
Agenda: On July 16, 2010, the committee will continue discussion on
topic 2.
On page 28028, in the first column, the Procedure portion of the
document is changed to read as follows:
Procedure: Oral presentations from the public (excluding the
tobacco industry) will be scheduled between approximately 10 a.m. and
11 a.m. on July 16, 2010.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: June 22, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-15554 Filed 6-23-10; 11:15 am]
BILLING CODE 4160-01-S